Syntex

Results: 55



#Item
21Microsoft Word[removed]ACUVAIL USPI 72555US12.doc

Microsoft Word[removed]ACUVAIL USPI 72555US12.doc

Add to Reading List

Source URL: www.allergan.com

Language: English - Date: 2015-01-06 19:01:33
22HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

Add to Reading List

Source URL: www.ariad.com

Language: English - Date: 2014-10-07 13:49:25
23TECHNOLOGY LAW UPDATE Syntex (U.S.A.) LLC v. Apotex, Inc. No[removed]

TECHNOLOGY LAW UPDATE Syntex (U.S.A.) LLC v. Apotex, Inc. No[removed]

Add to Reading List

Source URL: www.law.umaryland.edu

Language: English - Date: 2005-06-07 12:04:50
24ACULAR LS® Prescribing Information

ACULAR LS® Prescribing Information

Add to Reading List

Source URL: www.allergan.com

Language: English - Date: 2011-12-09 18:37:39
25BIOGRAPHY  NIKKI BIALY, PH.D., ASSOCIATE DIRECTOR Nikki Bialy (née Watson) has over 10 years of research experience at the bench in both academic and industry settings in Europe and the United States. She joined the fac

BIOGRAPHY NIKKI BIALY, PH.D., ASSOCIATE DIRECTOR Nikki Bialy (née Watson) has over 10 years of research experience at the bench in both academic and industry settings in Europe and the United States. She joined the fac

Add to Reading List

Source URL: www.alleninstitutecellscience.org

Language: English - Date: 2014-12-04 13:25:34
26Intranasal Analgesia… Maroli S et al  Journal of International Oral Health 2014; 6(1):66-71 Received: 10th August 2013 Accepted: 15th September 2013 Conflict of Interest: None Source of Support: Nil

Intranasal Analgesia… Maroli S et al Journal of International Oral Health 2014; 6(1):66-71 Received: 10th August 2013 Accepted: 15th September 2013 Conflict of Interest: None Source of Support: Nil

Add to Reading List

Source URL: www.intranasal.net

Language: English - Date: 2014-11-16 16:18:35
27HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-07-25 12:30:45
28An Old Drug Finds a New Use

An Old Drug Finds a New Use

Add to Reading List

Source URL: hsc.unm.edu

Language: English - Date: 2012-09-18 18:49:51
29Pain Control: Adult History Age Location Duration Severity[removed])

Pain Control: Adult History Age Location Duration Severity[removed])

Add to Reading List

Source URL: www.ncems.org

Language: English - Date: 2009-06-29 13:55:32
30HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information for ZYDELIG. ZYDELIG® (idelalisib) tablets, for or

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information for ZYDELIG. ZYDELIG® (idelalisib) tablets, for or

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-07-23 15:40:49